Thompson Elizabeth H.Z.
Insider CIK 1861477 · ACAD EVP, Head of Research & Dev · HZNP EVP, Research & Development · IGMS Director
Trades across companies
| Ticker | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|
| ACAD ACADIA PHARMACEUTICALS INC | S Sale | 2026-07-30 | 2026-07-31 | 16,508 | $26.13 | $431.4K | 19,044 | SEC↗ |
| ACAD ACADIA PHARMACEUTICALS INC | S Sale | 2026-07-30 | 2026-07-31 | 50 | $26.17 | $1.3K | 18,994 | SEC↗ |
| ACAD ACADIA PHARMACEUTICALS INC | S Sale | 2026-07-30 | 2026-07-31 | 50 | $26.17 | $1.3K | 18,994 | SEC↗ |
| ACAD ACADIA PHARMACEUTICALS INC | S Sale | 2026-07-30 | 2026-07-31 | 16,508 | $26.13 | $431.4K | 19,044 | SEC↗ |
| ACAD ACADIA PHARMACEUTICALS INC | M Exercise deriv | 2026-07-29 | 2026-07-31 | 32,272 | — | $0 | 32,272 | SEC↗ |
| ACAD ACADIA PHARMACEUTICALS INC | M Exercise | 2026-07-29 | 2026-07-31 | 32,272 | — | $0 | 35,552 | SEC↗ |
| ACAD ACADIA PHARMACEUTICALS INC | M Exercise deriv | 2026-07-29 | 2026-07-31 | 32,272 | — | $0 | 32,272 | SEC↗ |
| ACAD ACADIA PHARMACEUTICALS INC | M Exercise | 2026-07-29 | 2026-07-31 | 32,272 | — | — | 35,552 | SEC↗ |
| ACAD ACADIA PHARMACEUTICALS INC | S Sale | 2026-03-25 | 2026-03-26 | 3,435 | $21.47 | $73.7K | 3,280 | SEC↗ |
| ACAD ACADIA PHARMACEUTICALS INC | M Exercise deriv | 2026-03-24 | 2026-03-26 | 6,715 | — | $0 | 20,146 | SEC↗ |
| ACAD ACADIA PHARMACEUTICALS INC | M Exercise | 2026-03-24 | 2026-03-26 | 6,715 | — | $0 | 6,715 | SEC↗ |
| ACAD ACADIA PHARMACEUTICALS INC | A Award deriv | 2026-03-06 | 2026-03-10 | 29,548 | — | $0 | 29,548 | SEC↗ |
| ACAD ACADIA PHARMACEUTICALS INC | A Award deriv | 2026-03-06 | 2026-03-10 | 101,574 | — | $0 | 101,574 | SEC↗ |
| IGMS IGM Biosciences, Inc. | D To issuer | 2025-08-14 | 2025-08-14 | 7,196 | — | $0 | 0 | SEC↗ |
| IGMS IGM Biosciences, Inc. | A Award | 2025-06-30 | 2025-07-02 | 694 | — | $0 | 7,196 | SEC↗ |
| IGMS IGM Biosciences, Inc. | A Award | 2025-03-31 | 2025-04-02 | 694 | — | $0 | 6,502 | SEC↗ |
| ACAD ACADIA PHARMACEUTICALS INC | A Award deriv | 2025-03-24 | 2025-03-26 | 91,395 | — | $0 | 91,395 | SEC↗ |
| ACAD ACADIA PHARMACEUTICALS INC | A Award deriv | 2025-03-24 | 2025-03-26 | 26,861 | — | $0 | 26,861 | SEC↗ |
| IGMS IGM Biosciences, Inc. | A Award | 2024-12-31 | 2025-01-03 | 1,452 | — | $0 | 5,808 | SEC↗ |
| IGMS IGM Biosciences, Inc. | A Award | 2024-09-30 | 2024-10-02 | 1,452 | — | $0 | 4,356 | SEC↗ |
| ACAD ACADIA PHARMACEUTICALS INC | A Award deriv | 2024-08-12 | 2024-08-13 | 324,582 | — | $0 | 324,582 | SEC↗ |
| ACAD ACADIA PHARMACEUTICALS INC | A Award deriv | 2024-08-12 | 2024-08-13 | 64,544 | — | $0 | 64,544 | SEC↗ |
| IGMS IGM Biosciences, Inc. | A Award | 2024-06-28 | 2024-07-02 | 1,452 | — | $0 | 2,904 | SEC↗ |
| IGMS IGM Biosciences, Inc. | A Award | 2024-03-29 | 2024-04-02 | 1,452 | — | $0 | 1,452 | SEC↗ |
| IGMS IGM Biosciences, Inc. | A Award deriv | 2024-03-12 | 2024-03-14 | 29,400 | — | $0 | 29,400 | SEC↗ |
| HZNP Horizon Therapeutics Publi | D To issuer deriv | 2023-10-06 | 2023-10-06 | 5,174 | — | $0 | 0 | SEC↗ |
| HZNP Horizon Therapeutics Publi | D To issuer deriv | 2023-10-06 | 2023-10-06 | 14,283 | — | $0 | 0 | SEC↗ |
| HZNP Horizon Therapeutics Publi | D To issuer deriv | 2023-10-06 | 2023-10-06 | 21,426 | — | $0 | 0 | SEC↗ |
| HZNP Horizon Therapeutics Publi | D To issuer deriv | 2023-10-06 | 2023-10-06 | 10,349 | — | $0 | 0 | SEC↗ |
| HZNP Horizon Therapeutics Publi | D To issuer deriv | 2023-10-06 | 2023-10-06 | 12,854 | — | $0 | 0 | SEC↗ |
| HZNP Horizon Therapeutics Publi | D To issuer deriv | 2023-10-06 | 2023-10-06 | 5,174 | — | $0 | 0 | SEC↗ |
| HZNP Horizon Therapeutics Publi | D To issuer deriv | 2023-10-06 | 2023-10-06 | 20,697 | — | $0 | 0 | SEC↗ |
| HZNP Horizon Therapeutics Publi | D To issuer deriv | 2023-10-06 | 2023-10-06 | 4,285 | — | $0 | 0 | SEC↗ |
| HZNP Horizon Therapeutics Publi | D To issuer deriv | 2023-10-06 | 2023-10-06 | 4,657 | — | $0 | 0 | SEC↗ |
| HZNP Horizon Therapeutics Publi | D To issuer | 2023-10-06 | 2023-10-06 | 14,575 | $116.50 | $1.70M | 0 | SEC↗ |
| IGMS IGM Biosciences, Inc. | A Award deriv | 2023-10-03 | 2023-10-05 | 31,000 | — | $0 | 31,000 | SEC↗ |
| HZNP Horizon Therapeutics Publi | G Gift | 2023-03-13 | 2023-03-14 | 2,000 | — | $0 | 14,575 | SEC↗ |
| HZNP Horizon Therapeutics Publi | A Award deriv | 2023-01-04 | 2023-01-06 | 20,697 | — | $0 | 20,697 | SEC↗ |
| HZNP Horizon Therapeutics Publi | M Exercise deriv | 2022-12-30 | 2023-01-04 | 7,141 | — | $0 | 14,283 | SEC↗ |
| HZNP Horizon Therapeutics Publi | M Exercise deriv | 2022-12-30 | 2023-01-04 | 4,657 | — | $0 | 4,657 | SEC↗ |
| HZNP Horizon Therapeutics Publi | M Exercise deriv | 2022-12-30 | 2023-01-04 | 7,257 | — | $0 | 0 | SEC↗ |
| HZNP Horizon Therapeutics Publi | M Exercise | 2022-12-30 | 2023-01-04 | 19,055 | — | $0 | 26,024 | SEC↗ |
| HZNP Horizon Therapeutics Publi | F Tax w/h | 2022-12-30 | 2023-01-04 | 9,449 | $113.80 | $1.08M | 16,575 | SEC↗ |
| HZNP Horizon Therapeutics Publi | S Sale | 2022-07-20 | 2022-07-20 | 5,917 | $85.00 | $502.9K | 6,969 | SEC↗ |
| HZNP Horizon Therapeutics Publi | S Sale | 2022-07-19 | 2022-07-20 | 8 | $85.02 | $680 | 12,968 | SEC↗ |
| HZNP Horizon Therapeutics Publi | S Sale | 2022-07-19 | 2022-07-20 | 82 | $85.04 | $7.0K | 12,886 | SEC↗ |
| HZNP Horizon Therapeutics Publi | S Sale | 2022-07-07 | 2022-07-11 | 82 | $85.01 | $7.0K | 12,976 | SEC↗ |
| HZNP Horizon Therapeutics Publi | S Sale | 2022-04-18 | 2022-04-20 | 8,098 | $115.64 | $936.5K | 13,058 | SEC↗ |
| HZNP Horizon Therapeutics Publi | M Exercise deriv | 2022-01-05 | 2022-01-06 | 2,085 | — | $0 | 0 | SEC↗ |
| HZNP Horizon Therapeutics Publi | M Exercise deriv | 2022-01-05 | 2022-01-06 | 7,257 | — | $0 | 7,257 | SEC↗ |
| HZNP Horizon Therapeutics Publi | M Exercise deriv | 2022-01-05 | 2022-01-06 | 4,657 | — | $0 | 9,314 | SEC↗ |
| HZNP Horizon Therapeutics Publi | M Exercise | 2022-01-05 | 2022-01-06 | 13,999 | — | $0 | 28,186 | SEC↗ |
| HZNP Horizon Therapeutics Publi | F Tax w/h | 2022-01-05 | 2022-01-06 | 7,030 | $101.84 | $715.9K | 21,156 | SEC↗ |
| HZNP Horizon Therapeutics Publi | A Award deriv | 2022-01-04 | 2022-01-06 | 21,424 | — | $0 | 21,424 | SEC↗ |
| HZNP Horizon Therapeutics Publi | S Sale | 2021-08-05 | 2021-08-06 | 7,542 | $106.34 | $802.0K | 14,187 | SEC↗ |
| HZNP Horizon Therapeutics Publi | M Exercise deriv | 2021-07-01 | 2021-07-02 | 12,077 | — | $0 | 0 | SEC↗ |
| HZNP Horizon Therapeutics Publi | M Exercise | 2021-07-01 | 2021-07-02 | 12,077 | — | $0 | 27,717 | SEC↗ |
| HZNP Horizon Therapeutics Publi | F Tax w/h | 2021-07-01 | 2021-07-02 | 5,988 | $96.59 | $578.4K | 21,729 | SEC↗ |